A Study of Nemtabrutinib Versus Comparator in First Line Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma
The goal of this study is to evaluate nemtabrutinib compared with investigator’s choice of ibrutinib or acalabrutinib in participants with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) who have not received